Baidu
map

2022年3月1日简报:香港新增新冠肺炎确诊病例34466例;韩国新增病例全球领先;全球疫情加速好转,美国疾控中心进一步放松口罩佩戴要求

2022-03-01 MedSci整理 MedSci整理

截至北京时间2022年2月28日6时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过4亿3679万例,新增933,209例,达到436,790,2

截至北京时间2022年2月28日6时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎COVID-19)病例超过4亿3679万例,新增933,209例,达到436,790,237例。累计死亡病例597.2万例,达到5,972,979例。新增死亡为4,796例。康复为367,710,295例,重症和危重症病人达到75,030例;全球新冠确诊病例超过100万例的国家和地区达55个,124个国家和地区病例超10万例。昨日报道:2022年2月28日简报:香港新增新冠肺炎确诊病例26026例;国际疫情快速好转,全球开放重启在即;英国数据显示60岁以下的人群中,奥密克戎病死率为0.03%

 

香港新增34466例新冠肺炎确诊病例

香港特区政府卫生署卫生防护中心28日公布,截至当日零时,香港新增34466例新冠肺炎确诊病例。

据香港医管局介绍,过去24小时,再有87名确诊患者离世。

梁万年周一赴港,协助香港应对第五波疫情。他早前在接受采访时曾表示,香港人口密度大,病毒扩散风险比一般城市高,但大部分病例与境外输入相关,相信“动态清零”对香港仍然适用。他还说,“动态清零”不等于追求零感染,关键是一旦出现感染病例,能快速发现处置、精准管控及有效救治。

香港88.5%合资格人口已接种首剂新冠疫苗

香港特区政府公布,截至26日晚8时,香港已有超过595万人接种首剂新冠疫苗,合资格免费接种疫苗人数的88.5%(不含3至11岁人口),新冠疫苗接种总剂次近1300万。

香港特区政府自2021年2月26日起推出新冠疫苗接种计划,至今已满一年。根据特区政府公布的最新数据,截至26日晚8时,共有约595.9万名香港居民已接种首剂新冠疫苗,占合资格免费接种疫苗人数的88.5%;约517.9万名居民已接种第二剂新冠疫苗,占合资格免费接种疫苗人数的76.9%。

3岁至11岁居民,首剂新冠疫苗接种率为29.4%,第二剂为1.5%。

自2021年11月11日起,合资格香港居民可免费接种第三剂新冠疫苗。截至26日晚8时,第三剂新冠疫苗已有约166.9万人接种。

深圳“奥密克戎”病例无一重症

2月27日0-24时,深圳新增36例病例,主要由福田区、南山区报告。30例为新冠肺炎确诊病例,6例为新冠病毒无症状感染者,无重症。

目前,深圳全市奥密克戎病毒变异株新型冠状病毒感染者的病情以轻型为主(约占60%),无重型和危重型病例。

韩国新增139626例新冠确诊病例,全球第一,累计3134456例

韩国中央防疫对策本部2月28日通报,截至当天0时,韩国较前一天0时新增感染新型冠状病毒确诊病例13.9626万例,累计确诊313.4456万例。数据显示,韩国在不到一个月时间里累计新增约200万例新冠确诊病例。

由于周末检测量较少,单日新增确诊病例较前一天减少2.3939万例,时隔六天降至14万例以下。防疫部门认为,下月中旬将迎来“奥密克戎”疫情的峰值,届时单日新增病例将达到25万例左右。另外,对策本部将前一天通报的单日新增确诊病例数(16.3566万例)更正为16.3565万例。

韩国预测:单日新增确诊病例或将于3月9日超过23万例

2月28日,韩国疾病管理厅厅长郑银敬在例行记者会上表示,预计韩国境内单日新增新冠肺炎确诊病例将于3月9日超过23万例,接受住院治疗的危重症病例将增至1200例以上。

郑银敬说,综合国内外研究团队本月23日至24日进行的预测,奥密克戎扩散导致的本轮疫情峰值或出现在3月初至中旬,届时单日新增病例或将达18万至35万例。防疫部门将定期预测疫情走势,并调整应对方案。

此外,2月第四周(20日至26日)的韩国全国疫情风险程度被评为高级别。防疫部门称,随着奥密克戎成为境内主流毒株,单日新增病例和危重症病例均呈增加趋势,但医疗系统足以应对当前疫情。

奥密克戎疫情退潮 美国疾控中心进一步放松口罩佩戴要求

当地时间2月25日,美国疾病控制与预防中心(CDC)推出了新的新冠疫情风险等级体系,并大幅放宽了关于室内佩戴口罩的要求。

根据新规,美国72%的人口将不再需要在大部分室内公共场所佩戴口罩。新的指引方针表明,随着奥密克戎毒株在美国引起的新冠感染潮大幅消退,美国卫生官员将工作重点从预防病毒传播逐渐转向降低住院率和扩大医院接收能力等方面。

新的风险等级体系显示,全美只有不到三分之一的人口仍处于高风险地区,美国CDC建议这些地区的学校师生继续在室内佩戴口罩。

同时,在美国全国范围内乘坐飞机、火车、公共汽车以及出入机场和火车站等场所时仍需佩戴口罩。CDC主任瓦伦斯基预期这一规定将持续到3月18日,这那之前的几周内,CDC还将进一步修订防疫指引。

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1924224, encodeId=68c31924224ca, content=<a href='/topic/show?id=a37158322eb' target=_blank style='color:#2F92EE;'>#新增病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58322, encryptionId=a37158322eb, topicName=新增病例)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Sat Oct 29 01:16:56 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307900, encodeId=9aeb130e900bf, content=<a href='/topic/show?id=2be638263f4' target=_blank style='color:#2F92EE;'>#口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38263, encryptionId=2be638263f4, topicName=口罩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334926, encodeId=45e913349262e, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405377, encodeId=0f1b14053e725, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198489, encodeId=a10e119848967, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aa45585155, createdName=ms7000001165625582, createdTime=Tue Mar 01 21:05:49 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198265, encodeId=987b1198265b0, content=希望疫情能快点过去!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lpHJrtHiaxD12exW6icPqClj8O6xY2tlsEWan5wGcdf8dMDibWwR2icMGXFoUFSPTM8NgnV9BVruu23J0v2KKXicnlw/132, createdBy=2e682361427, createdName=Charm0707, createdTime=Tue Mar 01 09:05:06 CST 2022, time=2022-03-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1924224, encodeId=68c31924224ca, content=<a href='/topic/show?id=a37158322eb' target=_blank style='color:#2F92EE;'>#新增病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58322, encryptionId=a37158322eb, topicName=新增病例)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Sat Oct 29 01:16:56 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307900, encodeId=9aeb130e900bf, content=<a href='/topic/show?id=2be638263f4' target=_blank style='color:#2F92EE;'>#口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38263, encryptionId=2be638263f4, topicName=口罩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334926, encodeId=45e913349262e, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405377, encodeId=0f1b14053e725, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198489, encodeId=a10e119848967, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aa45585155, createdName=ms7000001165625582, createdTime=Tue Mar 01 21:05:49 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198265, encodeId=987b1198265b0, content=希望疫情能快点过去!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lpHJrtHiaxD12exW6icPqClj8O6xY2tlsEWan5wGcdf8dMDibWwR2icMGXFoUFSPTM8NgnV9BVruu23J0v2KKXicnlw/132, createdBy=2e682361427, createdName=Charm0707, createdTime=Tue Mar 01 09:05:06 CST 2022, time=2022-03-01, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1924224, encodeId=68c31924224ca, content=<a href='/topic/show?id=a37158322eb' target=_blank style='color:#2F92EE;'>#新增病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58322, encryptionId=a37158322eb, topicName=新增病例)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Sat Oct 29 01:16:56 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307900, encodeId=9aeb130e900bf, content=<a href='/topic/show?id=2be638263f4' target=_blank style='color:#2F92EE;'>#口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38263, encryptionId=2be638263f4, topicName=口罩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334926, encodeId=45e913349262e, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405377, encodeId=0f1b14053e725, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198489, encodeId=a10e119848967, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aa45585155, createdName=ms7000001165625582, createdTime=Tue Mar 01 21:05:49 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198265, encodeId=987b1198265b0, content=希望疫情能快点过去!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lpHJrtHiaxD12exW6icPqClj8O6xY2tlsEWan5wGcdf8dMDibWwR2icMGXFoUFSPTM8NgnV9BVruu23J0v2KKXicnlw/132, createdBy=2e682361427, createdName=Charm0707, createdTime=Tue Mar 01 09:05:06 CST 2022, time=2022-03-01, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1924224, encodeId=68c31924224ca, content=<a href='/topic/show?id=a37158322eb' target=_blank style='color:#2F92EE;'>#新增病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58322, encryptionId=a37158322eb, topicName=新增病例)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Sat Oct 29 01:16:56 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307900, encodeId=9aeb130e900bf, content=<a href='/topic/show?id=2be638263f4' target=_blank style='color:#2F92EE;'>#口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38263, encryptionId=2be638263f4, topicName=口罩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334926, encodeId=45e913349262e, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405377, encodeId=0f1b14053e725, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198489, encodeId=a10e119848967, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aa45585155, createdName=ms7000001165625582, createdTime=Tue Mar 01 21:05:49 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198265, encodeId=987b1198265b0, content=希望疫情能快点过去!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lpHJrtHiaxD12exW6icPqClj8O6xY2tlsEWan5wGcdf8dMDibWwR2icMGXFoUFSPTM8NgnV9BVruu23J0v2KKXicnlw/132, createdBy=2e682361427, createdName=Charm0707, createdTime=Tue Mar 01 09:05:06 CST 2022, time=2022-03-01, status=1, ipAttribution=)]
    2022-03-02 zutt
  5. [GetPortalCommentsPageByObjectIdResponse(id=1924224, encodeId=68c31924224ca, content=<a href='/topic/show?id=a37158322eb' target=_blank style='color:#2F92EE;'>#新增病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58322, encryptionId=a37158322eb, topicName=新增病例)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Sat Oct 29 01:16:56 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307900, encodeId=9aeb130e900bf, content=<a href='/topic/show?id=2be638263f4' target=_blank style='color:#2F92EE;'>#口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38263, encryptionId=2be638263f4, topicName=口罩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334926, encodeId=45e913349262e, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405377, encodeId=0f1b14053e725, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198489, encodeId=a10e119848967, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aa45585155, createdName=ms7000001165625582, createdTime=Tue Mar 01 21:05:49 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198265, encodeId=987b1198265b0, content=希望疫情能快点过去!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lpHJrtHiaxD12exW6icPqClj8O6xY2tlsEWan5wGcdf8dMDibWwR2icMGXFoUFSPTM8NgnV9BVruu23J0v2KKXicnlw/132, createdBy=2e682361427, createdName=Charm0707, createdTime=Tue Mar 01 09:05:06 CST 2022, time=2022-03-01, status=1, ipAttribution=)]
    2022-03-01 ms7000001165625582

    加油

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1924224, encodeId=68c31924224ca, content=<a href='/topic/show?id=a37158322eb' target=_blank style='color:#2F92EE;'>#新增病例#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58322, encryptionId=a37158322eb, topicName=新增病例)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/xkicoVBAnV4HxvdCqC1viaW8wdLQdN9hVP9icgqqDsxC6UVPjfhogdfc2iaU1xNUMVlFl5QicicWrjWQBTsVye5ngOQQ/132, createdBy=f92f2500185, createdName=ms7405317358118777, createdTime=Sat Oct 29 01:16:56 CST 2022, time=2022-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1307900, encodeId=9aeb130e900bf, content=<a href='/topic/show?id=2be638263f4' target=_blank style='color:#2F92EE;'>#口罩#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=38263, encryptionId=2be638263f4, topicName=口罩)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f52347, createdName=soongzhihua, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1334926, encodeId=45e913349262e, content=<a href='/topic/show?id=d16910002215' target=_blank style='color:#2F92EE;'>#韩国#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100022, encryptionId=d16910002215, topicName=韩国)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=99cf2500102, createdName=zjshifan_98647306, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405377, encodeId=0f1b14053e725, content=<a href='/topic/show?id=3f67e0632c0' target=_blank style='color:#2F92EE;'>#疾控中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70632, encryptionId=3f67e0632c0, topicName=疾控中心)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/0AD7956C8522FF8EF9A242DC5569528A/100, createdBy=d51a2536255, createdName=zutt, createdTime=Wed Mar 02 22:16:56 CST 2022, time=2022-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198489, encodeId=a10e119848967, content=加油, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1aa45585155, createdName=ms7000001165625582, createdTime=Tue Mar 01 21:05:49 CST 2022, time=2022-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198265, encodeId=987b1198265b0, content=希望疫情能快点过去!, beContent=null, objectType=article, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/lpHJrtHiaxD12exW6icPqClj8O6xY2tlsEWan5wGcdf8dMDibWwR2icMGXFoUFSPTM8NgnV9BVruu23J0v2KKXicnlw/132, createdBy=2e682361427, createdName=Charm0707, createdTime=Tue Mar 01 09:05:06 CST 2022, time=2022-03-01, status=1, ipAttribution=)]
    2022-03-01 Charm0707

    希望疫情能快点过去!

    0

相关资讯

2022年2月28日简报:香港新增新冠肺炎确诊病例26026例;国际疫情快速好转,全球开放重启在即;英国数据显示60岁以下的人群中,奥密克戎病死率为0.03%

截至北京时间2022年2月28日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过4亿3465万例,新增1,302,795例,达到434,656

丹麦研究:感染过奥密克戎原始毒株 仍可能感染BA.2

BA.2亚型毒株是最早英国发现的奥密克戎毒株新变种,与BA.1是同属于“奥密克戎家族”的“表亲”。

2022年2月24日简报:香港新增新冠肺炎确诊病例8674例;韩国单日新增确诊首超17万例,政府认为从长远看奥密克戎扩散有利于恢复日常; 全球重症病人再次低于8万人

截至北京时间2022年2月24日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过4亿2970万例,新增1,713,097例,达到429,706

2022年2月27日简报:香港新增新冠肺炎确诊病例17063例,死亡病例66例,疫情处于加速扩散期;日本发现奥密克戎进一步变异版本BA.1.1 

截至北京时间2022年2月28日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过4亿3465万例,新增1,302,795例,达到434,656

2022年2月25日简报:昨日新增本土病例82例,涉13省份;香港新增8798例新冠肺炎确诊病例;奥密克戎新变种BA.2已在美国30多州传播;国药集团针对奥密克戎开发了4款新冠疫苗

截至北京时间2022年2月25日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过4亿3160万例,新增1,713,706例。

2022年2月26日简报:香港新增10010例新冠肺炎确诊病例;全国新冠疫苗接种超31亿剂次;全球主要发达国家疫情明显好转

截至北京时间2022年2月26日7时01分,Worldometers世界实时统计数据显示,全球累计确诊新冠肺炎(COVID-19)病例超过4亿3328万例,新增1,602,429例,达到433,288

Baidu
map
Baidu
map
Baidu
map